TMED
Exchange-traded product on NASDAQ (US)
- Type
- Exchange-traded product
- Share class
- —
- Status
- listed
- ISIN
- —
- Currency
- —
- Represents the company
- No
Holdings as of Jun 30, 2026
The full portfolio as of the quarter end Jun 30, 2026, from the fund's report to the SEC (Form N-PORT, filed Aug 27, 2026), the newest we have: we do not read a daily file from this fund's website, or the filing is newer. Every line is listed: holdings we could identify link to their page, the rest (bonds, CLOs, loans, derivatives, securities we do not carry) are shown as filed, debt with its coupon and maturity; Shares is the principal amount for debt. Short positions are negative. Change is the share count against the filing of Mar 31, 2026.
102 lines, 93 linked, weights sum to 100.00% · Actively managed (N-CEN)
| Holding | Ticker / identifier | Type | Shares | Change | Weight | Market value |
|---|---|---|---|---|---|---|
| ELI LILLY & CO | US5324571083 | Equity | 3,209 | +20 | 16.71% | $ 3.849M |
| UNITEDHEALTH GROUP INC | US91324P1021 | Equity | 3,614 | −1,284 | 6.52% | $ 1.502M |
| GILEAD SCIENCES INC | US3755581036 | Equity | 8,084 | +2,064 | 4.44% | $ 1.021M |
| THERMO FISHER SCIENTIFIC INC | US8835561023 | Equity | 1,890 | −3 | 4.11% | $ 947.57K |
| DANAHER CORP | US2358511028 | Equity | 3,580 | +662 | 2.96% | $ 681.918K |
| CENCORA INC | US03073E1055 | Equity | 2,240 | +1,555 | 2.75% | $ 633.875K |
| AGILENT TECHNOLOGIES INC | US00846U1016 | Equity | 4,530 | +1,534 | 2.61% | $ 601.72K |
| ALNYLAM PHARMACEUTICALS INC | US02043Q1076 | Equity | 1,986 | +724 | 2.60% | $ 597.846K |
| INTUITIVE SURGICAL INC | US46120E6023 | Equity | 1,410 | +1,276 | 2.43% | $ 560.729K |
| INSULET CORP | US45784P1012 | Equity | 3,601 | +2,798 | 2.38% | $ 548.252K |
| STRYKER CORP | US8636671013 | Equity | 1,624 | +389 | 2.22% | $ 511.3K |
| DYNE THERAPEUTICS INC | US26818M1080 | Equity | 21,069 | +100 | 2.03% | $ 467.942K |
| ELANCO ANIMAL HEALTH INC | US28414H1032 | Equity | 17,864 | +4,436 | 1.91% | $ 439.633K |
| PFIZER INC | US7170811035 | Equity | 18,228 | new +18,228 | 1.91% | $ 438.93K |
| CYTOKINETICS INC | US23282W6057 | Equity | 4,564 | −158 | 1.69% | $ 388.807K |
| WATERS CORP | US9418481035 | Equity | 1,034 | −158 | 1.68% | $ 387.791K |
| WEST PHARMACEUTICAL SERVICES | US9553061055 | Equity | 1,060 | −138 | 1.65% | $ 380.54K |
| ASCENDIS PHARMA A/S | DK0060615755 | Equity | 1,382 | new +1,382 | 1.60% | $ 368.607K |
| BIOGEN INC | US09062X1037 | Equity | 1,654 | +264 | 1.55% | $ 357.363K |
| MCKESSON CORP | US58155Q1031 | Equity | 444 | new +444 | 1.46% | $ 335.486K |
| DEXCOM INC | US2521311074 | Equity | 4,976 | +1,725 | 1.46% | $ 335.134K |
| IMMUNOME INC | US45257U1088 | Equity | 15,009 | +4,340 | 1.38% | $ 318.041K |
| BIONTECH SE-ADR | US09075V1026 | Equity | 3,188 | +1,359 | 1.29% | $ 296.643K |
| HUMANA INC | US4448591028 | Equity | 721 | −1,114 | 1.24% | $ 286.396K |
| DENALI THERAPEUTICS INC | US24823R1059 | Equity | 10,962 | +5,846 | 1.22% | $ 281.943K |
| CVS HEALTH CORP | US1266501006 | Equity | 2,717 | +19 | 1.22% | $ 281.074K |
| IDEXX LABORATORIES INC | US45168D1046 | Equity | 515 | +249 | 1.18% | $ 271.117K |
| VAXCYTE INC | US92243G1085 | Equity | 4,655 | +519 | 1.18% | $ 270.595K |
| METTLER-TOLEDO INTERNATIONAL | US5926881054 | Equity | 174 | −4 | 0.97% | $ 222.287K |
| HCA HEALTHCARE INC | US40412C1018 | Equity | 562 | new +562 | 0.95% | $ 219.118K |
| IMMATICS NV | NL0015285941 | Equity | 19,722 | +3,354 | 0.87% | $ 199.784K |
| REPLIGEN CORP | US7599161095 | Equity | 1,430 | +71 | 0.85% | $ 195.109K |
| ELEVANCE HEALTH INC | US0367521038 | Equity | 456 | new +456 | 0.77% | $ 176.349K |
| SHATTUCK LABS INC | US82024L1035 | Equity | 25,348 | +1,237 | 0.76% | $ 175.915K |
| APOGEE THERAPEUTICS INC | US03770N1019 | Equity | 1,309 | −349 | 0.75% | $ 173.744K |
|
STATE STREET INS US GO MM FD-IS
|
US8574927062 | Money market | 169,172.27 | +142,163.98 | 0.73% | $ 169.172K |
| BECTON DICKINSON AND CO | US0758871091 | Equity | 1,098 | −1,104 | 0.72% | $ 166.16K |
| MOONLAKE IMMUNOTHERAPEUTICS | KY61559X1045 | Equity | 7,823 | −1,896 | 0.66% | $ 152.314K |
| COOPER COS INC/THE | US2166485019 | Equity | 2,088 | −109 | 0.65% | $ 149.73K |
| CABALETTA BIO INC | US12674W1099 | Equity | 45,659 | +2,029 | 0.62% | $ 141.999K |
| CG ONCOLOGY INC | US1569441009 | Equity | 1,996 | −32 | 0.62% | $ 141.816K |
| TENET HEALTHCARE CORP | US88033G4073 | Equity | 693 | new +693 | 0.56% | $ 129.646K |
| BICARA THERAPEUTICS INC | US0554771032 | Equity | 4,103 | −4,207 | 0.53% | $ 121.818K |
| ALIGNMENT HEALTHCARE INC | US01625V1044 | Equity | 4,840 | new +4,840 | 0.50% | $ 115.24K |
| SAREPTA THERAPEUTICS INC | US8036071004 | Equity | 6,068 | −749 | 0.47% | $ 109.042K |
| KYMERA THERAPEUTICS INC | US5015751044 | Equity | 949 | −548 | 0.47% | $ 108.822K |
| REVVITY INC | US7140461093 | Equity | 926 | new +926 | 0.45% | $ 103.027K |
| ADAPTIVE BIOTECHNOLOGIES | US00650F1093 | Equity | 4,479 | −7,605 | 0.42% | $ 96.075K |
| MOLINA HEALTHCARE INC | US60855R1005 | Equity | 416 | −666 | 0.41% | $ 95.139K |
| BEONE MEDICINES LTD-ADR | US07725L1026 | Equity | 322 | new +322 | 0.40% | $ 91.76K |
| MAPLIGHT THERAPEUTICS INC | US56565P1030 | Equity | 2,543 | −2,567 | 0.40% | $ 91.141K |
| AKESO INC | KYG0146B1032 | Equity | 8,000 | new +8,000 | 0.39% | $ 90.078K |
| KODIAK SCIENCES INC | US50015M1099 | Equity | 2,147 | −558 | 0.36% | $ 83.647K |
| GENEDX HOLDINGS CORP | US81663L2007 | Equity | 1,200 | +309 | 0.36% | $ 82.38K |
| DIANTHUS THERAPEUTICS INC | US2528281080 | Equity | 816 | −32 | 0.35% | $ 79.544K |
| AVALO THERAPEUTICS INC | US05338F3064 | Equity | 4,287 | −2,627 | 0.34% | $ 79.224K |
| INCYTE CORP | US45337C1027 | Equity | 669 | −729 | 0.33% | $ 75.838K |
| 4D MOLECULAR THERAPEUTICS IN | US35104E1001 | Equity | 5,545 | new +5,545 | 0.32% | $ 73.749K |
| XENON PHARMACEUTICALS INC | CA98420N1050 | Equity | 1,216 | −1,342 | 0.32% | $ 73.398K |
| NOVOCURE LTD | JE00BYSS4X48 | Equity | 4,764 | −3,834 | 0.31% | $ 72.175K |
| EIKON THERAPEUTICS INC | US2825641036 | Equity | 5,522 | −318 | 0.31% | $ 72.062K |
| ORUKA THERAPEUTICS INC | US6876041087 | Equity | 746 | new +746 | 0.31% | $ 70.997K |
| STOKE THERAPEUTICS INC | US86150R1077 | Equity | 2,167 | −301 | 0.31% | $ 70.904K |
| ONKURE THERAPEUTICS INC | US68277Q1058 | Equity | 15,335 | new +15,335 | 0.30% | $ 69.928K |
| STEVANATO GROUP SPA | IT0005452658 | Equity | 3,869 | −2,640 | 0.30% | $ 69.913K |
| SARTORIUS AG | DE0007165607 | Equity | 320 | new +320 | 0.30% | $ 68.734K |
| CARIS LIFE SCIENCES INC | US1421521071 | Equity | 3,694 | +317 | 0.29% | $ 65.827K |
| KARDIGAN INC | US4859251013 | Equity | 2,695 | new +2,695 | 0.28% | $ 64.276K |
| CRINETICS PHARMACEUTICALS IN | US22663K1079 | Equity | 1,596 | −162 | 0.26% | $ 59.722K |
| GRAIL INC | US3847471014 | Equity | 868 | −536 | 0.26% | $ 59.258K |
| ARCUS BIOSCIENCES INC | US03969F1093 | Equity | 1,868 | −1,965 | 0.25% | $ 57.59K |
| MAZE THERAPEUTICS INC | US5787841007 | Equity | 1,656 | new +1,656 | 0.21% | $ 49.415K |
| AKTIS ONCOLOGY INC | US01021M1045 | Equity | 1,517 | −1,204 | 0.21% | $ 48.893K |
| ALLOGENE THERAPEUTICS INC | US0197701065 | Equity | 23,151 | new +23,151 | 0.21% | $ 48.154K |
| ORIC PHARMACEUTICALS INC | US68622P1093 | Equity | 4,380 | new +4,380 | 0.21% | $ 47.435K |
| RAPPORT THERAPEUTICS INC | US75383L1026 | Equity | 1,127 | −2,265 | 0.20% | $ 46.962K |
| AMYLYX PHARMACEUTICALS INC | US03237H1014 | Equity | 2,611 | −3,100 | 0.20% | $ 46.894K |
| Spyre Therapeutics Inc | US00773J2024 | Equity | 525 | new +525 | 0.20% | $ 46.61K |
|
Damora Therapeutics Inc
|
US36322Q2066 | Equity | 1,788 | new +1,788 | 0.20% | $ 46.506K |
| ENLIVEN THERAPEUTICS INC | US29337E1029 | Equity | 891 | −244 | 0.20% | $ 45.218K |
| PROCEPT BIOROBOTICS CORP | US74276L1052 | Equity | 1,951 | +501 | 0.19% | $ 44.054K |
| DISC MEDICINE INC | US2546041011 | Equity | 600 | −241 | 0.19% | $ 43.884K |
| AVALYN PHARMA INC | US05348Y1055 | Equity | 1,244 | new +1,244 | 0.18% | $ 40.952K |
| IONIS PHARMACEUTICALS INC | US4622221004 | Equity | 509 | −341 | 0.18% | $ 40.359K |
| SCHRODINGER INC | US80810D1037 | Equity | 2,236 | +574 | 0.16% | $ 36.335K |
| BLACK DIAMOND THERAPEUTICS I | US09203E1055 | Equity | 15,259 | −284 | 0.12% | $ 28.229K |
| ABIVAX SA-ADR | US00370M1036 | Equity | 209 | new +209 | 0.12% | $ 27.851K |
| ERASCA INC | US29479A1088 | Equity | 1,460 | −4,888 | 0.12% | $ 26.747K |
| PERSONALIS INC | US71535D1063 | Equity | 1,990 | −1,990 | 0.12% | $ 26.666K |
| KARYOPHARM THERAPEUTICS INC | US48576U2050 | Equity | 2,470 | −2,014 | 0.10% | $ 24.132K |
| PRIME MEDICINE INC | US74168J1016 | Equity | 6,152 | −12,299 | 0.10% | $ 22.701K |
| IMMUNOVANT INC | US45258J1025 | Equity | 580 | −168 | 0.10% | $ 22.347K |
| BIOHAVEN LTD | VGG1110E1079 | Equity | 1,458 | −3,165 | 0.09% | $ 21.695K |
| CRISPR THERAPEUTICS AG | CH0334081137 | Equity | 381 | −328 | 0.09% | $ 20.78K |
|
KARYOPHARM WTS 10.28 TC4ZZLSW8
|
Equity | 3,159 | 0 | 0.08% | $ 17.514K | |
| ANNEXON INC | US03589W1027 | Equity | 2,087 | −7,228 | 0.05% | $ 11.917K |
|
JASPER THERA WTS 3/30 TC8U3IZJ8
|
Equity | 5,370 | 0 | 0.01% | $ 1,524.01 | |
|
CONTRA 89BIO INC COMMON STOCK
|
US282CVR0187 | Equity | 2,477 | 0 | 0.00% | $ 0.00 |
|
CENTESSA PHARMACEUTICALS-ADR CVR
|
152CVR015 | Equity | 1,490 | new +1,490 | 0.00% | $ 0.00 |
|
CONTRA APELLIS PHARMAC COMMON STOCK
|
US037CVR0169 | Equity | 499 | new +499 | 0.00% | $ 0.00 |
|
APPLIED THERAPEUTICS INC CVR
|
APLT 038CVR031 | Equity | 153,622 | 0 | 0.00% | $ 0.00 |
|
METSERA INC CVR
|
MTSR 592CVR013 | Equity | 1,892 | 0 | 0.00% | $ 0.00 |